Hankyel Park

Array ( [id] => 1275434 [patent_doc_number] => 06649744 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action' [patent_app_type] => B1 [patent_app_number] => 10/009457 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26862 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 287 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649744.pdf [firstpage_image] =>[orig_patent_app_number] => 10009457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779386 [patent_doc_number] => 20030050468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Synthetic HIV gag genes' [patent_app_type] => new [patent_app_number] => 09/974702 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11799 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050468.pdf [firstpage_image] =>[orig_patent_app_number] => 09974702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845271 [patent_doc_number] => 20020132769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Targeting molecules' [patent_app_type] => new [patent_app_number] => 09/971798 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15898 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132769.pdf [firstpage_image] =>[orig_patent_app_number] => 09971798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326507 [patent_doc_number] => 06599728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-29 [patent_title] => 'Second mammalian tankyrase' [patent_app_type] => B2 [patent_app_number] => 09/972115 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37678 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599728.pdf [firstpage_image] =>[orig_patent_app_number] => 09972115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311336 [patent_doc_number] => 06610473 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Peptides for inhibiting HPV E6-proteins' [patent_app_type] => B1 [patent_app_number] => 09/889136 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3637 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610473.pdf [firstpage_image] =>[orig_patent_app_number] => 09889136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340698 [patent_doc_number] => 20020034509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Methods and compositions for ameliorating the symptoms of sepsis' [patent_app_type] => new [patent_app_number] => 09/970338 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12410 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034509.pdf [firstpage_image] =>[orig_patent_app_number] => 09970338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1506984 [patent_doc_number] => 06440691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Melanins with improved ability to inhibit HIV replication' [patent_app_type] => B1 [patent_app_number] => 09/969448 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7651 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440691.pdf [firstpage_image] =>[orig_patent_app_number] => 09969448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656659 [patent_doc_number] => 20030077755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Protein fragments for use in protein targeting' [patent_app_type] => new [patent_app_number] => 09/968255 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 19168 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077755.pdf [firstpage_image] =>[orig_patent_app_number] => 09968255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6782914 [patent_doc_number] => 20030064361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'HIV envelopolype peptides' [patent_app_type] => new [patent_app_number] => 09/966931 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19365 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064361.pdf [firstpage_image] =>[orig_patent_app_number] => 09966931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1145742 [patent_doc_number] => 06773916 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Agents and methods for treatment and diagnosis of ocular disorders' [patent_app_type] => B1 [patent_app_number] => 09/857399 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15637 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773916.pdf [firstpage_image] =>[orig_patent_app_number] => 09857399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405146 [patent_doc_number] => 20020037535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Use of mCRP to slow cell growth and to promote maturation of cells' [patent_app_type] => new [patent_app_number] => 09/957280 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8846 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037535.pdf [firstpage_image] =>[orig_patent_app_number] => 09957280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749901 [patent_doc_number] => 20030044421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications' [patent_app_type] => new [patent_app_number] => 09/952060 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 144 [patent_figures_cnt] => 144 [patent_no_of_words] => 41053 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044421.pdf [firstpage_image] =>[orig_patent_app_number] => 09952060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377700 [patent_doc_number] => 20020119495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Immunogenic composition of hepatitis C and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/952572 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18577 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119495.pdf [firstpage_image] =>[orig_patent_app_number] => 09952572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828212 [patent_doc_number] => 20020068273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT\n(mitochondrial adenine nucleotide translocator)' [patent_app_type] => new [patent_app_number] => 09/949650 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14946 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068273.pdf [firstpage_image] =>[orig_patent_app_number] => 09949650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6241388 [patent_doc_number] => 20020044945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Novel feline immunodeficiency virus nucleotide sequence' [patent_app_type] => new [patent_app_number] => 09/946239 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9076 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20020044945.pdf [firstpage_image] =>[orig_patent_app_number] => 09946239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6934251 [patent_doc_number] => 20010055595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-27 [patent_title] => 'Detection and treatment of infections with immunoconjugates' [patent_app_type] => new [patent_app_number] => 09/935567 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12455 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20010055595.pdf [firstpage_image] =>[orig_patent_app_number] => 09935567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220382 [patent_doc_number] => 06703226 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-09 [patent_title] => 'Expression of a foamy virus envelope protein' [patent_app_type] => B1 [patent_app_number] => 09/923317 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7100 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703226.pdf [firstpage_image] =>[orig_patent_app_number] => 09923317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356790 [patent_doc_number] => 20020058044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Complex Of Lipo-Viro-Particles, Method Of Preparation And Applications' [patent_app_type] => new [patent_app_number] => 09/917915 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5805 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058044.pdf [firstpage_image] =>[orig_patent_app_number] => 09917915 [rel_patent_id] =>[rel_patent_doc_number] =>)